Flow cytometric DNA analysis, and immunohistochemical p53, PCNA and histopathologic study in primary achalasia: Preliminary results

Hepato-Gastroenterology

Volumn 48, Issue 38, 2001, Pages 408-412

  Bektas, A ^a   Yasa, M H ^a   Kuzu, I ^a   Dogan, I ^a   Unal S ^a   Ormeci N ^a  

^a ONDOKUZ MAYIS UNIVERSITY   (Turkey)

Author keywords

DNA ploidy; p53; Primary achalasia; Proliferating cell nuclear antigen (PCNA)

Indexed keywords

CYCLINE; DNA; PROTEIN P53;

ADULT; ANEUPLOIDY; ARTICLE; CANCER GROWTH; CELL HYPERPLASIA; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; DNA DETERMINATION; DYSPLASIA; ESOPHAGITIS; ESOPHAGUS ACHALASIA; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; FEMALE; FLOW CYTOMETRY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL;

EID: 0035042022     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Achalasia of the esophagus: Pathologic and etiologic considerations
2. The natural history of achalasia of the cardia
3. Achalasia and carcinoma of the esophagus
4. Achalasia-associated squamous cell carcinoma of the esophagus: Flow-cytometric and histological evaluation
5. The p53 tumor suppressor gene
6. Accumulation of p53 protein in human esophageal precancerous lesions: A possible early biomarker for carcinogenesis
7. p53: The ultimate tumor suppressor gene?
8. Autoantibody to a nuclear antigen in proliferating cells
9. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histologic grade, S+G2+M phase fraction (flow cytometric analysis) and prognosis
10. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
11. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair
12. Biologic characteristics of esophageal epithelial dysplasia assessed by proliferating cell nuclear antigen
13. Flow cytometric and histological progression to malignancy in Barrett's esophagus: Prospective endoscopic surveillance of a cohort
14. Barrett's esophagus: Correlation between flow cytometry and histology in detection of patients at risk for adenocarcinoma
15. Precursor lesions of esophageal cancer in high-risk populations in Henan province, China
16. The multicentric occurrence of squamous epithelial dysplasia and squamous cell carcinoma in esophagus
17. Histological classification of intraepithelial neoplasias and microinvasive squamous carcinoma of the esophagus
18. Achalasia
19. Achalasia and carcinoma of the esophagus
20. Achalasia and carcinoma of the esophagus
21. Achalasia: A morphologic study of 42 resected specimens
22. Early detection of malignancy in ulcerative colitis. A flow cytometric study
23. Flow cytometric detection of aneuploidy in colorectal adenomas
24. Barrett's esophagus: Cell cycle abnormalities in advancing stages of neoplastic progression
25. Flow cytometry in squamous cell esophageal cancer and precancerous lesions
26. Flow cytometric analysis of DNA heterogeneity in superficial carcinoma of the esophagus
27. Intratumoral heterogeneity in DNA ploidy of esophageal squamous cell carcinoma
28. Flow cytometric analysis of DNA stemline heterogeneity in primary and metastatic breast cancer
29. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: A review
30. p53 tumor suppressor gene mutation in early esophageal precancerous lesions and carcinoma among high-risk populations in Henan, China
31. Accumulation of p53 protein in human esophageal precancerous lesions: A possible early biomarker for carcinogenesis
32. Update on proliferation-associated antibodies applicable to formalin fixed paraffin embedded tissue and their clinical applications
33. Proliferating cell antigen in esophageal diseases: Correlation with transforming growth factor alpha expression
34. Proliferating cell nuclear antigen in assessment of Barrett's mucosa
35. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma